Ayla Ellison

Chicago

Editor-in-Chief at Fierce Healthcare

Editor-in-Chief at Fierce Biotech

Editor-in-Chief at FiercePharma

Editor-in-Chief, Healthcare & Life Sciences, at Questex @FierceBiotech @FierceHealth @FiercePharma @FierceMedtech

Featured in: Favicon

fiercehealthcare.com Favicon

fiercebiotech.com Favicon

fiercepharma.com Favicon

globalresearch.ca Favicon

beckershospitalreview.com Favicon

beckersasc.com Favicon

beckersspine.com Favicon

ramaonhealthcare.com Favicon

einnews.com

Articles

Providers, payers brace for regulatory uncertainty in Q1

1 day ago | fiercehealthcare.com | Ayla Ellison |Paige Minemyer |Dave Muoio

The healthcare industry is preparing for significant regulatory change in the latter half of 2025, and much of the conversation on the first quarter earnings calls was about setting the tone for those complications. Tariffs, Medicaid cuts and the likely end of the enhanced ACA subsidies all have major implications for payers and providers, and industry behemoth UnitedHealth Group is headlining those trends with an unusual miss and the departure of its CEO, Andrew Witty.
Angela Hwang on her pivot from Big Pharma to biotech

6 days ago | fiercepharma.com | Ayla Ellison |Angus Liu

Angela Hwang spent nearly three decades at Pfizer before joining Flagship Pioneering in 2025 as a CEO-partner and the CEO of Metaphore Biotechnologies. In this week’s episode of "The Top Line," the former Pfizer chief commercial officer speaks with Fierce Pharma Deputy Editor Angus Liu about her transition from marketing drugs at a Big Pharma company to advancing novel technology at a young biotech startup.
The rise of AI scribes: What’s the real-world impact?

1 week ago | fiercehealthcare.com | Ayla Ellison |Emma Beavins

AI scribes have seen rapid growth in the healthcare market over the past year, but reliable data on their actual performance is still hard to come by. Much of the available information comes from vendor claims, leaving a gap in independent, real-world assessments.
ElevAAte and the push for East Asian American leaders in biopharma

1 week ago | fiercepharma.com | Ayla Ellison |Angus Liu

Although East Asians make up a significant share of entry-level roles in U.S. biopharma, few have risen to senior leadership positions. That disparity is what inspired the launch of ElevAAte—a new nonprofit founded this year to support and grow East Asian American leadership in the industry. In this week’s episode of "The Top Line," Fierce Pharma Deputy Editor Angus Liu speaks with two of ElevAAte’s co-founders: Architect Therapeutics CEO Angie You and Candid Therapeutics CEO Ken Song.
ElevAAte and the push for East Asian American leaders in biopharma

1 week ago | asianamericans.einnews.com | Ayla Ellison |Angus Liu

Although East Asians make up a significant share of entry-level roles in U.S. biopharma, few have risen to senior leadership positions. That disparity is what inspired the launch of ElevAAte—a new nonprofit founded this year to support and grow East Asian American leadership in the industry. In this week’s episode of "The Top Line," Fierce Pharma Deputy Editor Angus Liu speaks with two of ElevAAte’s co-founders: Architect Therapeutics CEO Angie You and Candid Therapeutics CEO Ken Song.
Human-centered design in healthcare

2 weeks ago | fiercehealthcare.com | Ayla Ellison |Anastassia Gliadkovskaya

Human-centered design is crucial in healthcare—but it’s often invisible. Rooted in systems thinking, it considers the broader ecosystems that shape patient needs. Design can make or break a patient’s experience. Yet many organizations don’t fully understand what this approach involves or how to implement it effectively. CannonDesign works across sectors, including healthcare, to help organizations design smarter.
Angus on Angus: A Fierce oncology discussion

2 weeks ago | fiercepharma.com | Ayla Ellison |Angus Liu

We’ve known for a while that there are two Anguses—both journalists covering oncology at health- and biopharma-focused news outlets. Now, for the first time, we’re bringing them together for a “Variety Studio: Actors on Actors”-style conversation. In this week’s episode of "The Top Line," Fierce Pharma Deputy Editor Angus Liu and STAT Cancer Reporter Angus Chen share insights into their work covering cancer and their thoughts on racial identity during a tumultuous time.
Managing diabetes with cultural foods

3 weeks ago | fiercehealthcare.com | Ayla Ellison |Anastassia Gliadkovskaya

About 1 in 10 people have diabetes, and 1 in 5 don’t even know they have it. Preventing and managing diabetes is only possible when you know where to start. Yumlish provides nutrition literacy to Medicaid and Medicare populations in a culturally diverse way. This week on "Podnosis," Senior Writer Anastassia Gliadkovskaya speaks with Yumlish founder and CEO Shireen Abdullah about the outcomes Yumlish is seeing and how federal budget cuts risk making diabetes prevalence worse.
Navigating Trump’s tariffs for pharma

3 weeks ago | fiercepharma.com | Ayla Ellison |Fraiser Kansteiner

After a batch of much-anticipated reciprocal tariffs spared pharmaceuticals in early April, drugmakers, medtech companies, manufacturers and other outfits across the life sciences spectrum are still scrambling to respond to mounting trade pressures. While many unknowns remain, biopharma companies should waste no time in starting to evaluate their options.
A look at the gaps in eating disorder care

4 weeks ago | fiercehealthcare.com | Ayla Ellison |Anastassia Gliadkovskaya

Nearly 30 million Americans will have an eating disorder in their lifetime. Unfortunately, there aren’t enough providers who know how to treat these complex conditions. What care is available is largely inaccessible, often for financial or geographical reasons. Equip, a virtual provider of eating disorder treatment services, recently ran a survey of nearly 500 people who have been in or are currently in treatment.